Mira Pharmaceuticals Inc (NASDAQ: MIRA) kicked off on Monday, down -6.67% from the previous trading day, before settling in for the closing price of $1.8. Over the past 52 weeks, MIRA has traded in a range of $0.62-$5.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -224.25%. While this was happening, its average annual earnings per share was recorded 26.67%. With a float of $12.90 million, this company’s outstanding shares have now reached $16.81 million.
Let’s determine the extent of company efficiency that accounts for 5 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mira Pharmaceuticals Inc (MIRA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Mira Pharmaceuticals Inc is 25.79%, while institutional ownership is 5.47%. The most recent insider transaction that took place on Nov 19 ’24, was worth 77,020. In this transaction Chief Executive Officer of this company sold 55,410 shares at a rate of $1.39, taking the stock ownership to the 1,105,790 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Chief Executive Officer sold 44,590 for $1.27, making the entire transaction worth $56,629. This insider now owns 1,061,200 shares in total.
Mira Pharmaceuticals Inc (MIRA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 26.67% per share during the next fiscal year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
Take a look at Mira Pharmaceuticals Inc’s (MIRA) current performance indicators. Last quarter, stock had a quick ratio of 12.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.50, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
Looking closely at Mira Pharmaceuticals Inc (NASDAQ: MIRA), its last 5-days average volume was 2.27 million, which is a jump from its year-to-date volume of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 74.70%.
During the past 100 days, Mira Pharmaceuticals Inc’s (MIRA) raw stochastic average was set at 69.85%, which indicates a significant increase from 59.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1921 in the past 14 days, which was higher than the 0.1163 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3249, while its 200-day Moving Average is $1.2181.
